A single volume collection that surveys the exciting field of plant-made pharmaceuticals and industrial proteins
This comprehensive book communicates the recent advances and exciting potential for the expanding area of plant biotechnology and is divided into six sections. The first three sections look at the current status of the field, and advances in plant platforms and strategies for improving yields, downstream processing, and controlling post-translational modifications of plant-made recombinant proteins. Section four reviews high-value industrial and pharmacological proteins that are successfully being produced in established and emerging plant platforms. The fifth section looks at regulatory challenges facing the expansion of the field. The final section turns its focus toward small molecule therapeutics, drug screening, plant specialized metabolites, and plants as model organisms to study human disease processes.
Molecular Pharming: Applications, Challenges and Emerging Areas
offers in-depth coverage of molecular biology of plant expression systems and manipulation of glycosylation processes in plants; plant platforms, subcellular targeting, recovery, and downstream processing; plant-derived protein pharmaceuticals and case studies; regulatory issues; and emerging areas. It is a valuable resource for researchers that are in the field of plant molecular pharming, as well as for those conducting basic research in gene expression, protein quality control, and other subjects relevant to molecular and cellular biology.
Broad ranging coverage of a key area of plant biotechnology
Describes efforts to produce pharmaceutical and industrial proteins in plants
Provides reviews of recent advances and technology breakthroughs
Assesses realities of regulatory and cost hurdles
Forward looking with coverage of small molecule technologies and the use of plants as models of human disease processes
Providing wide-ranging and unique coverage,
will be of great interest to the plant science, plant biotechnology, protein science, and pharmacological communities.